Connect with us

Hi, what are you looking for?

Captain Of Success
Top Stories

Stock Markets

DoH secretary resignation sought

THE PHILIPPINES’ top health official should step down if he fails to uphold the commitment to make healthcare affordable for Filipinos, a congressman said on Thursday, urging the Department of Health (DoH) to stay true to the promises it made to Congress before yearend.

Health Secretary Teodoro J. Herbosa and Emmanuel R. Ledesma, Jr., president of state-run Philippine Health Insurance Corp. (PhilHealth), promised the House of Representatives last month they’ll make medical care cheaper by increasing health insurance benefits while expanding its coverage, according to Party-list Rep. Wilbert T. Lee.

“What should be focused on now is the implementation of the commitment that DoH Secretary Ted Herbosa and PhilHealth Chief Mandy Ledesma signed, aimed at significantly lowering the hospital expenses of Filipinos,” he said in a statement in Filipino.

“If Secretary Herbosa has no intention of fulfilling the agreement, he should resign now,” he added.

PhilHealth and the DoH promised to institute a 50% across-the-board health benefit increase and to cover at least 80% of cancer treatment and heart operation expenses by November 2024, according to a commitment letter signed by Mr. Herbosa and Mr. Ledesma.

They also agreed to make various health diagnostic scans, such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) free, making it part of outpatient services rendered by PhilHealth.

Meanwhile, Iloilo Rep. Janette L. Garin said amendments to the Universal Health Care Act should be taken up instead of replacing the heads of Philippine health agencies, noting the need to review “restrictive” provisions.

“We can change the PhilHealth chief a hundred times but unless we amend the law as soon as possible, Universal Health Care can never be achieved,” Ms. Garin, a former Health secretary, said. “I call on the leadership of both Houses to make the amendment… a priority.”

She cited the need to ease clinical trial restrictions on drugs and medical devices entering Philippine markets. Only a Phase III clinical trial approval would suffice for most medicines, enough to consider it “safe and efficacious.”

Clinical trials are studies to determine the effectiveness and safety of new medicines and other forms of medical treatment.

Sec. 34 of the 2019 health law mandated that pharmaceutical products and medical procedures should undergo a Phase IV clinical trial before being allowed in the country.

“With this requirement of Phase IV, Filipinos will have no recourse but to go to other countries to gain access to any breakthrough in science,” she said. “This Section 34… is just one of the many provisions deemed restrictive and detrimental to health care accessibility.” — Kenneth Christiane L. Basilio

    You May Also Like

    Finance

    When you’re considering a redesign or migration of your website, one of the primary concerns is preserving your SEO efforts. Even a seemingly minor...

    Finance

    The European Union has voted to impose tariffs of up to 35% on Chinese electric vehicles, a decision that has divided member states and...

    Finance

    The Confederation of British Industry (CBI) has urged Chancellor Rachel Reeves to introduce significant tax cuts for electric car, heat pump, and biofuel manufacturers...

    Finance

    US dockworkers have agreed to end a three-day strike that brought shipping to a standstill along the east and Gulf coasts, after reaching a...

    Disclaimer: CaptainOfSuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Captain Of Success. All Rights Reserved.